CrisprBits raises 250,000 USD in pre-seed funding The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial…
CrisprBits develops CRISPR-based SARS-CoV2 test with Omicron detection OmiCrisp has been developed with support from Centre for Cellular And Molecular Platforms C-CAMP-InDx Program
New COVID-like rapid test to spot cancers, heart disease more easily The new test, called CrisprZyme, works by detecting molecular signals in the body called biomarkers, which are already used in…
Otago researchers contribute to international study helping improve understanding of bacteria,… Researchers at University of Exeter, UK, with support from University of Montpellier, France, Otago team, found that existing…